Kamada (KMDA) VP grants and surrenders 112,500 stock options under 2011 plan

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

KAMADA LTD VP of Operations Nir Eran reported compensation-related option adjustments held through a trustee under the company’s 2011 Share Award Plan. On April 7, 2026, he received grants of a total of 112,500 Employee Stock Options to buy Ordinary Shares and surrendered 112,500 options back to the company.

The grants include tranches of 22,500 options at exercise prices of $5.87 and $7.25 per share, with corresponding dispositions of 22,500 options at $6.12 and $7.50. Footnotes state exercise prices are translated from NIS and were adjusted under the 2011 Share Award Plan in connection with a cash dividend distribution, with all other award terms unchanged. The options vest in four equal annual installments starting on the grant date anniversaries and some tranches expire on August 28, 2028 while others expire on October 22, 2035.

Insider Trade Summary

10 transactions reported

Mixed 10 txns

Insider Nir Eran

Role VP, Operations

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	22,500	$0.00	--
Disposition	Employee Stock Option (right to buy)	22,500	$0.00	--
Grant/Award	Employee Stock Option (right to buy)	22,500	$0.00	--
Disposition	Employee Stock Option (right to buy)	22,500	$0.00	--
Grant/Award	Employee Stock Option (right to buy)	22,500	$0.00	--
Disposition	Employee Stock Option (right to buy)	22,500	$0.00	--
Grant/Award	Employee Stock Option (right to buy)	22,500	$0.00	--
Disposition	Employee Stock Option (right to buy)	22,500	$0.00	--
Grant/Award	Employee Stock Option (right to buy)	22,500	$0.00	--
Disposition	Employee Stock Option (right to buy)	22,500	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 22,500 shares (Indirect, Held by trustee)

Footnotes (1)

All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan.

Key Figures

Options granted: 112,500 options Options surrendered: 112,500 options Lower strike price tranche: $5.87 per share +5 more

8 metrics

Options granted 112,500 options Total Employee Stock Options granted on April 7, 2026

Options surrendered 112,500 options Total options disposed to issuer on April 7, 2026

Lower strike price tranche $5.87 per share Employee Stock Option exercise price translated from NIS

Higher strike price tranche $7.50 per share Employee Stock Option exercise price translated from NIS

Intermediate strike price $7.25 per share Employee Stock Option exercise price for several tranches

Near-term expiration August 28, 2028 Expiration date for one option series

Long-term expiration October 22, 2035 Expiration date for multiple option tranches

Vesting schedule 25% annually over 4 years Options vest on each anniversary of grant date

Key Terms

Employee Stock Option (right to buy), 2011 Share Award Plan, cash dividend distribution, exercise price, +1 more

5 terms

Employee Stock Option (right to buy) financial

"security_title: "Employee Stock Option (right to buy)" for each transaction"

cash dividend distribution financial

"in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026"

exercise price financial

"All exercise prices presented in U.S. dollars represent a convenience conversion from NIS"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Held by trustee financial

"Held by trustee under the Company's 2011 Share Award Plan."

Form 4 Insider Transactions: What Each Field Means →

04/09/2026 - 02:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nir Eran

(Last)

(First)

(Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$5.87⁽¹⁾⁽²⁾	04/07/2026		A		22,500		02/28/2026⁽³⁾	08/28/2028	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$6.12⁽¹⁾	04/07/2026		D			22,500	02/28/2026⁽³⁾	08/28/2028	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		22,500		10/22/2026⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			22,500	10/22/2026⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		22,500		10/22/2027⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			22,500	10/22/2027⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		22,500		10/22/2028⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			22,500	10/22/2028⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		22,500		10/22/2029⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			22,500	10/22/2029⁽³⁾	10/22/2035	Ordinary Shares	22,500	⁽²⁾	22,500	I	Held by trustee⁽⁴⁾

Explanation of Responses:

1. All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

2. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

3. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

4. Held by trustee under the Company's 2011 Share Award Plan.

	/s/ Eran Nir	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Kamada (KMDA) report for Nir Eran?

Kamada reported that VP of Operations Nir Eran had 112,500 Employee Stock Options granted and 112,500 options surrendered to the company. All options relate to Ordinary Shares and are held by a trustee under Kamada’s 2011 Share Award Plan as part of his compensation package.

Were Nir Eran’s Kamada (KMDA) option transactions open-market buys or sells?

The filing shows no open-market buys or sells. It records option grants coded “A” (grant or award) and dispositions coded “D” (disposition to issuer), all under the company’s 2011 Share Award Plan, rather than trades in the public market.

What are the exercise prices of the Kamada (KMDA) options for Nir Eran?

The reported Employee Stock Options have exercise prices of $5.87, $6.12, $7.25, and $7.50 per Ordinary Share. Footnotes explain these U.S. dollar amounts are convenience translations from NIS using the Bank of Israel exchange rate published on April 6, 2026.

How do Nir Eran’s Kamada (KMDA) option awards vest and when do they expire?

The options vest in four equal installments, with 25% vesting on each of the four anniversaries of the grant date. Certain tranches expire on August 28, 2028, while others have an expiration date of October 22, 2035, giving long-dated equity exposure.

Why were Kamada (KMDA) option exercise prices for Nir Eran adjusted?

Footnotes state the option exercise prices were adjusted under Kamada’s 2011 Share Award Plan following a cash dividend distribution declared by the board on March 11, 2026. The filing notes there are no other changes to the terms and conditions of the option award.

How are Nir Eran’s Kamada (KMDA) options held according to the Form 4?

The Form 4 shows the options are held indirectly, coded “I”, by a trustee. A footnote clarifies they are held by a trustee under Kamada’s 2011 Share Award Plan, indicating plan administration rather than direct personal record ownership of the option certificates.